(Q34086259)

30 July 2017

1 reference

title

The pharmacokinetics of glycyrrhizic acid evaluated by physiologically based pharmacokinetic modeling (English)

1 reference

30 July 2017

1 reference

Ploeger B

1

1 reference

30 July 2017

Mensinga T

2

1 reference

30 July 2017

Sips A

3

1 reference

30 July 2017

Seinen W

4

1 reference

30 July 2017

Meulenbelt J

5

1 reference

30 July 2017

DeJongh J

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

30 July 2017

published in

Drug Metabolism Reviews

1 reference

30 July 2017

volume

33

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

125-147

1 reference

Historical perspectives on health. The history of liquorice: the plant, its extract, cultivation, commercialisation and etymology

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Review article: glycyrrhizin as a potential treatment for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

The determination of glycyrrhizin in selected UK liquorice products

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Administration-route dependency of absorption of glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Interaction of licorice on glycyrrhizin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Glycyrrhizin .BETA.-D-glucuronidase of Eubacterium sp. from human intestinal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

In vitro and in vivo evaluation of the enhancing activity of glycyrrhizin on the intestinal absorption of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Endogenous inhibitors of 11 beta-OHSD: existence and possible significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Prediction of glycyrrhizin disposition in rat and man by a physiologically based pharmacokinetic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Pharmacokinetics of glycyrrhizin after intravenous administration to rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

NCOMP--a windows-based computer program for noncompartmental analysis of pharmacokinetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Optimum numerical integration methods for estimation of area-under-the-curve (AUC) and area-under-the-moment-curve (AUMC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Dose-dependent pharmacokinetics: experimental observations and theoretical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Disposition of glycyrrhizin in the perfused liver of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

The formation of beta-glucuronidase resistant glucuronides by the intramolecular rearrangement of glucuronic acid conjugates at mild alkaline pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Applying Simulation Modeling to Problems in Toxicology and Risk Assessment: A Short Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Simulation of toluene kinetics in the rat by a physiologically based pharmacokinetic model with application of biotransformation parameters derived independently in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Physiologically based pharmacokinetic modeling of glycyrrhizic acid, a compound subject to presystemic metabolism and enterohepatic cycling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

A human physiologically-based model for glycyrrhzic acid, a compound subject to presystemic metabolism and enterohepatic cycling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Analysis and pharmacokinetics of glycyrrhizic acid and glycyrrhetinic acid in humans and experimental animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

A population physiologically based pharmacokinetic/pharmacodynamic model for the inhibition of 11-beta-hydroxysteroid dehydrogenase activity by glycyrrhetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Liver transferase activity in healthy Japanese employees aged 18-39 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Incorporation of pharmacokinetics in noncancer risk assessment: example with chloropentafluorobenzene

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Effects of gender, age, and body mass index on gastrointestinal transit times

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Influence of age, gender, hormonal status and smoking habits on colonic transit time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

Variability of gastrointestinal transit in healthy women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDMR-100104400

21 January 2018

Identifiers

DOI

10.1081/DMR-100104400

1 reference

30 July 2017

1 reference